Search

Your search keyword '"Ni, Ai"' showing total 497 results

Search Constraints

Start Over You searched for: Author "Ni, Ai" Remove constraint Author: "Ni, Ai"
497 results on '"Ni, Ai"'

Search Results

1. The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer

2. BatMan: Mitigating Batch Effects via Stratification for Survival Outcome Prediction

3. Matched Design for Marginal Causal Effect on Restricted Mean Survival Time in Observational Studies

4. Dose adjustment of paroxetine based on CYP2D6 activity score inferred metabolizer status in Chinese Han patients with depressive or anxiety disorders: a prospective study and cross-ethnic meta-analysis

6. Performance Evaluation of Transcriptomics Data Normalization for Survival Risk Prediction

7. Matched design for marginal causal effect on restricted mean survival time in observational studies

12. Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

17. Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: a multicentre, single-arm, phase 2 trial

25. Copy number variation is highly correlated with differential gene expression: a pan-cancer study

26. CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma

28. Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

35. scCATCH: Automatic Annotation on Cell Types of Clusters from Single-Cell RNA Sequencing Data

36. Adding spatial distribution clue to aggregated vector in image retrieval

40. Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

42. Efficient, Multicolored, and Stable Room‐Temperature Phosphorescence Doped Materials Based on a Lead Halide Matrix: A Coordination‐Driven Doping Strategy.

44. Revealing topics and their evolution in biomedical literature using Bio-DTM: a case study of ginseng

45. A Bioactive Chemical Markers Based Strategy for Quality Assessment of Botanical Drugs: Xuesaitong Injection as a Case Study

46. Asymmetric expression of CA2 and CA13 linked to calcification in the bilateral mandibular condyles cause crossed beaks in chickens

47. Figure S2 from A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

48. Supplemental Tables 1-4, Supplemental Figures 1-2 from Effects of Co-occurring Genomic Alterations on Outcomes in Patients with KRAS-Mutant Non–Small Cell Lung Cancer

49. Supplementary Tables from A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

50. supplemental tables and figures from Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance

Catalog

Books, media, physical & digital resources